IGFBP1 and metabolic dysfunction-associated steatotic liver disease: In NAFLD, fS-IGFBP-1 has been shown to be decreased in studies involving 142 Japanese subjects8, 48 Italian women9, and 49 African American and 77 Latino adolescents10.